Pharmacology of Sclerotherapy
نویسندگان
چکیده
منابع مشابه
PHARMACOLOGY OF PHLEBOLOGY Phillip Artemi MECHANISM OF ACTION OF SCLEROTHERAPY GENERAL MECHANISM FOR PRODUCING ENDOTHELIAL DAMAGE
Total endothelial destruction results in the exposure of sub-endothelial collagen fibers causing platelet aggregation, adherence, and release of platelet-related factors. This series of events initiates the intrinsic pathway of blood coagulation by activating factor XII. Ideally, sclerosing solutions otherwise should not cause activation or release of thromboplastic activity because this would ...
متن کاملPharmacology and Toxicology of Leflunomide
Leflunomide (LEF), used for rheumatoid arthritis, inhibits dihydro-orotate dehydrogenase (DHODH) and tyrosine kinase (TK) enzymes and has anti-inflammatory, lymphocyte proliferation regulatory, immunosuppression and chondroprotective effects. The most common adverse effects are gastrointestinal disorders, weight loss, hypertension, skin infection, and neurological and hematological toxicity. It...
متن کاملSclerotherapy for Baker's Cyst.
Centeno and coworkers (Pain Physician 2008: 11: 257-262) brought to light a very important subject (1). Historically, installation of irritating substances into a pathologic, fluid filled cavity has been known since Aurelius Cornelius Celsus (25 B.C.– 50 A.D.) described the injection of saltpeter (potassium nitrate), to cure hydrocele (2,3). Contemporary work with sodium morrhuate (SM) began in...
متن کاملHow Does Endoscopic Sclerotherapy
Endoscopic sclerotherapy is widely employed for esophageal variceal hemorrhage. However it has side effects and can aggravate portal hypertension by suppression of portosystemic shunt. The purpose of the present investigation was to study the effect of variceal thrombosis on hepatic venous pressure gradient and azygos blood flow. Eight alcoholic cirrhotic patients with a first variceal hemorrha...
متن کاملPost - Sclerotherapy Hyperpigmentation
Introduction Postsclerotherapy hyperpigmentation following the treatment of either varicose veins and/or visible blood vessles (telangiectasias) in the lower limbs has always been a major problem for the phlebologist. In literature there are conflicting data on the true incidence of this complication. In some studies the incidence is estimated in 30% of patients treated with sodium tetradecyl s...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Seminars in Interventional Radiology
سال: 2010
ISSN: 0739-9529,1098-8963
DOI: 10.1055/s-0030-1267848